Pierre Mounkoro

A role for the succinate dehydrogenase in the mode of action of the redox-active antimalarial drug, plasmodione.

E. Davioud‐Charvet, S. Blandin, B. Meunier, 2020, Free radical biology & medicine.

Conducting a Complex Sociological Survey in Rural Mali

C. Schooler, L. Caplan, J. Vogel, 1998 .

The antimalarial compound ELQ‐400 is an unusual inhibitor of the bc1 complex, targeting both Qo and Qi sites

B. Iorga, B. Meunier, Zehua Song, 2018, FEBS letters.

Investigating the mode of action of the redox-active antimalarial drug plasmodione using the yeast model.

E. Davioud‐Charvet, S. Blandin, B. Meunier, 2019, Free radical biology & medicine.

Successful use of empagliflozin to treat neutropenia in two G6PC3‐deficient children: Impact of a mutation in SGLT5

M. Veiga-da-Cunha, E. Van Schaftingen, X. Stephenne, 2022, Journal of inherited metabolic disease.

Mitochondrial complex III Qi -site inhibitor resistance mutations found in laboratory selected mutants and field isolates.

B. Iorga, B. Meunier, G. Surpateanu, 2019, Pest management science.

Revisiting the mode of action of the antimalarial proguanil using the yeast model.

B. Meunier, T. Michel, Pierre Mounkoro, 2020, Biochemical and biophysical research communications.